Terms: = Breast cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK
826 results:
1. Application research of radiomics in colorectal cancer: A bibliometric study.
Yang L; Wang B; Shi X; Li B; Xie J; Wang C
Medicine (Baltimore); 2024 Apr; 103(15):e37827. PubMed ID: 38608072
[TBL] [Abstract] [Full Text] [Related]
2. Selective impact of alk and MELK inhibition on ERα stability and cell proliferation in cell lines representing distinct molecular phenotypes of breast cancer.
Bartoloni S; Pescatori S; Bianchi F; Cipolletti M; Acconcia F
Sci Rep; 2024 Apr; 14(1):8200. PubMed ID: 38589728
[TBL] [Abstract] [Full Text] [Related]
3. Effects of pharmacogenetics on pharmacokinetics and toxicity of doxorubicin in Egyptian breast cancer patients.
Ebaid NF; Abdelkawy KS; Shehata MA; Salem HF; Magdy G; Hussein RRS; Elbarbry F
Xenobiotica; 2024 Mar; 54(3):160-170. PubMed ID: 38491961
[TBL] [Abstract] [Full Text] [Related]
4. Risk factors for severe complications and salvage management in direct-to-implant immediate breast reconstruction: A retrospective study.
Zhu M; Mao J; Fang J; Chen D
Medicine (Baltimore); 2024 Mar; 103(10):e37365. PubMed ID: 38457600
[TBL] [Abstract] [Full Text] [Related]
5. Emerging role of tumor suppressing microRNAs as therapeutics in managing non-small cell lung cancer.
Singh S; Saxena S; Sharma H; Paudel KR; Chakraborty A; MacLoughlin R; Oliver BG; Gupta G; Negi P; Singh SK; Dua K
Pathol Res Pract; 2024 Apr; 256():155222. PubMed ID: 38452582
[TBL] [Abstract] [Full Text] [Related]
6. An ultrasound-based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and external validation.
Zheng Q; Yan H; He Y; Wang J; Zhang N; Huo L; Liu Y; Wang L; Xu L; Fan Z
Cancer; 2024 Apr; 130(S8):1513-1523. PubMed ID: 38427584
[TBL] [Abstract] [Full Text] [Related]
7. Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants.
Kim N; Cho WK; Park W; Lee JE; Nam SJ; Kim SW; Yu J; Chae BJ; Lee SK; Ryu JM; Ko ES; Kim H
Breast Cancer; 2024 May; 31(3):391-400. PubMed ID: 38368487
[TBL] [Abstract] [Full Text] [Related]
8. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
Yarmolinsky J; Robinson JW; Mariosa D; Karhunen V; Huang J; Dimou N; Murphy N; Burrows K; Bouras E; Smith-Byrne K; Lewis SJ; Galesloot TE; Kiemeney LA; Vermeulen S; Martin P; Albanes D; Hou L; Newcomb PA; White E; Wolk A; Wu AH; Le Marchand L; Phipps AI; Buchanan DD; ; ; Zhao SS; Gill D; Chanock SJ; Purdue MP; Davey Smith G; Brennan P; Herzig KH; Järvelin MR; Amos CI; Hung RJ; Dehghan A; Johansson M; Gunter MJ; Tsilidis KK; Martin RM
EBioMedicine; 2024 Feb; 100():104991. PubMed ID: 38301482
[TBL] [Abstract] [Full Text] [Related]
9. Association of High-Deductible Health Plans and Time to Surgery for breast and Colon cancer.
Sheckter CC; Rochlin DH; Rubenstein R; Shamsunder MG; Morris AM; Wagner TH; Matros E
J Am Coll Surg; 2023 Sep; 237(3):473-482. PubMed ID: 38085770
[TBL] [Abstract] [Full Text] [Related]
10. Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: a National cancer Database Analysis.
Li H; Plichta JK; Li K; Jin Y; Thomas SM; Ma F; Tang L; Wei Q; He YW; Chen Q; Guo Y; Liu Y; Zhang J; Luo S
Breast Cancer Res Treat; 2024 Feb; 204(1):89-105. PubMed ID: 38066250
[TBL] [Abstract] [Full Text] [Related]
11. High-grade intraductal carcinoma of the parotid gland harboring CTNNA1::alk rearrangement: Changes in genetic status using genetic testing during treatment with an alk inhibitor.
Watanabe T; Honma Y; Yonemori K; Sunami K; Yoshimoto S; Mori T
Head Neck; 2024 Mar; 46(3):E26-E31. PubMed ID: 38018800
[TBL] [Abstract] [Full Text] [Related]
12. Benefits and Harms of Mammography Screening in 75 + Women to Inform Shared Decision-making: a Simulation Modeling Study.
Jayasekera J; Stein S; Wilson OWA; Wojcik KM; Kamil D; Røssell EL; Abraham LA; O'Meara ES; Schoenborn NL; Schechter CB; Mandelblatt JS; Schonberg MA; Stout NK
J Gen Intern Med; 2024 Feb; 39(3):428-439. PubMed ID: 38010458
[TBL] [Abstract] [Full Text] [Related]
13. cancer incidence during the COVID-19 pandemic by region of residence in Manitoba, Canada: A cancer registry-based interrupted time series study.
Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Singh H; Thiessen M; Pitz M; Musto G; Galloway K; Lambert P
Cancer Med; 2023 Dec; 12(23):21465-21479. PubMed ID: 37974380
[TBL] [Abstract] [Full Text] [Related]
14. breast Imaging Patient Demographics at a Major Comprehensive cancer Center Before and During the COVID-19 Pandemic.
Cohen EO; Edelkamp P; Sun J; Leung JWT
J Am Coll Radiol; 2024 Apr; 21(4):576-588. PubMed ID: 37952808
[TBL] [Abstract] [Full Text] [Related]
15. Machine learning applied in patient-reported outcome research-exploring symptoms in adjuvant treatment of breast cancer.
Pappot H; Björnsson BP; Krause O; Bæksted C; Bidstrup PE; Dalton SO; Johansen C; Knoop A; Vogelius I; Holländer-Mieritz C
Breast Cancer; 2024 Jan; 31(1):148-153. PubMed ID: 37940813
[TBL] [Abstract] [Full Text] [Related]
16. Treatment utilization and effectiveness of neoadjuvant chemotherapy comparing men and women diagnosed with breast cancer: a Swedish retrospective cohort study.
Schiza A; Fredriksson I; Sund M; Valachis A
Breast Cancer Res Treat; 2024 Jan; 203(2):235-243. PubMed ID: 37812362
[TBL] [Abstract] [Full Text] [Related]
17. European Real-World Assessment of the Clinical Validity of a CE-IVD Panel for Ultra-Fast Next-Generation Sequencing in Solid Tumors.
Normanno N; Machado JC; Pescarmona E; Buglioni S; Navarro L; Esposito Abate R; Ferro A; Mensink R; Lambiase M; Lespinet-Fabre V; Calgua B; Jermann PM; Ilié M; Hofman P
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762091
[TBL] [Abstract] [Full Text] [Related]
18. Rate and Timeliness of Diagnostic Evaluation and Biopsy After Recall From Screening Mammography in the National Mammography Database.
Oluyemi ET; Grimm LJ; Goldman L; Burleson J; Simanowith M; Yao K; Rosenberg RD
J Am Coll Radiol; 2024 Mar; 21(3):427-438. PubMed ID: 37722468
[TBL] [Abstract] [Full Text] [Related]
19. 21-gene expression assay and clinical outcomes of premenopausal patients with hormone receptor-positive breast cancer.
Hyung J; Lee SB; Kim J; Kim HJ; Ko B; Lee JW; Son BH; Lee HJ; Gong G; Jeong H; Jeong JH; Kim JE; Ahn JH; Jung KH; Kim SB
Int J Cancer; 2024 Feb; 154(4):748-756. PubMed ID: 37718333
[TBL] [Abstract] [Full Text] [Related]
20. Rare HER2 L796P missense mutation promotes the growth and oncogenic signaling in breast cancer cells.
Zhang D; Shi X; Zheng W; Zhang X; Chen Y
Proteomics Clin Appl; 2024 Jan; 18(1):e2300061. PubMed ID: 37672800
[TBL] [Abstract] [Full Text] [Related]
[Next]
